1.0EMUC25https://emuc.orgLoek Keizerhttps://emuc.org/author/loek/rich600338<blockquote class="wp-embedded-content" data-secret="rqU3pAf5Ks"><a href="https://emuc.org/trial-presentations-guideline-changing-potential/">Trial presentations to have “Guideline-changing potential”</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://emuc.org/trial-presentations-guideline-changing-potential/embed/#?secret=rqU3pAf5Ks" width="600" height="338" title="“Trial presentations to have “Guideline-changing potential”” — EMUC25" data-secret="rqU3pAf5Ks" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> https://emuc.org/wp-content/uploads/2019/08/Dr-Tobias-Maurer-scaled.jpg25601518“Onco-urology is a rapidly-evolving field. Next to classical systemic therapies such as androgen deprivation in prostate cancer or chemotherapy, immunotherapeutical approaches or newer, more potent antiandrogens are increasingly incorporated in the armamentarium of medical uro-oncologists,” says urologist Dr. Tobias Maurer (Hamburg, DE). “It is up to well-designed prospective studies to determine their exact indication and place in the landscape in […]